Literature DB >> 2578619

G to A substitution in the distal CCAAT box of the A gamma-globin gene in Greek hereditary persistence of fetal haemoglobin.

R Gelinas, B Endlich, C Pfeiffer, M Yagi, G Stamatoyannopoulos.   

Abstract

The sequence 5'TTGGPyCAAT 3' (the 'CCAAT box') is a constituent of the promoter region of many eukaryotic and prokaryotic genes and is believed to play a part in promoter function. A characteristic of the two fetal human globin genes (A gamma and G gamma) is a duplication of a 12-base pair (bp) sequence containing the CCAAT box. Here we report a G----A substitution in the TTG sequence of the distal CCAAT box of the A gamma-globin gene in an individual with the A gamma (Greek) type of hereditary persistence of fetal haemoglobin (HPFH). This represents the first report of a natural mutation of the CCAAT box in a eukaryotic gene. The fact that this transition is associated with inappropriate expression of the A gamma gene in adult life suggests that the CCAAT box (or its surrounding sequences) may have a role in the developmental control of gamma-globin genes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2578619     DOI: 10.1038/313323a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  60 in total

1.  An embryonic/fetal beta-type globin gene repressor contains a nuclear receptor TR2/TR4 heterodimer.

Authors:  Osamu Tanabe; Fumiki Katsuoka; Andrew D Campbell; Weimin Song; Masayuki Yamamoto; Keiji Tanimoto; James Douglas Engel
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

Review 2.  Cell signaling pathways involved in drug-mediated fetal hemoglobin induction: Strategies to treat sickle cell disease.

Authors:  Betty S Pace; Li Liu; Biaoru Li; Levi H Makala
Journal:  Exp Biol Med (Maywood)       Date:  2015-08

Review 3.  Control of globin gene expression during development and erythroid differentiation.

Authors:  George Stamatoyannopoulos
Journal:  Exp Hematol       Date:  2005-03       Impact factor: 3.084

4.  Adult stage gamma-globin silencing is mediated by a promoter direct repeat element.

Authors:  Akane Omori; Osamu Tanabe; James Douglas Engel; Akiyoshi Fukamizu; Keiji Tanimoto
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

5.  Analysis of 5' flanking regions of the gamma globin genes from major African haplotype backgrounds associated with sickle cell disease.

Authors:  S R Month; R W Wood; P T Trifillis; P J Orchowski; B Sharon; S K Ballas; S Surrey; E Schwartz
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

6.  A novel C-T transition within the distal CCAAT motif of the G gamma-globin gene in the Japanese HPFH: implication of factor binding in elevated fetal globin expression.

Authors:  S Fucharoen; K Shimizu; Y Fukumaki
Journal:  Nucleic Acids Res       Date:  1990-09-11       Impact factor: 16.971

7.  Translocation of an erythroid-specific hypersensitive site in deletion-type hereditary persistence of fetal hemoglobin.

Authors:  J T Elder; W C Forrester; C Thompson; D Mager; P Henthorn; M Peretz; T Papayannopoulou; M Groudine
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

8.  Functional profile of the human fetal gamma-globin gene upstream promoter region.

Authors:  H J Lin; C Y Han; A W Nienhuis
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

9.  Silencing of Agamma-globin gene expression during adult definitive erythropoiesis mediated by GATA-1-FOG-1-Mi2 complex binding at the -566 GATA site.

Authors:  Susanna Harju-Baker; Flávia C Costa; Halyna Fedosyuk; Renee Neades; Kenneth R Peterson
Journal:  Mol Cell Biol       Date:  2008-03-17       Impact factor: 4.272

10.  The Nuclear Factor Y subunits NF-YB2 and NF-YB3 play additive roles in the promotion of flowering by inductive long-day photoperiods in Arabidopsis.

Authors:  Roderick W Kumimoto; Luc Adam; Graham J Hymus; Peter P Repetti; T Lynne Reuber; Colleen M Marion; Frederick D Hempel; Oliver J Ratcliffe
Journal:  Planta       Date:  2008-07-04       Impact factor: 4.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.